Aesthetic Surgery Journal
An Analysis of Safety Data from Five Phase III Clinical Trials on the Use of Botulinum Neurotoxin Type A-ABO for the Treatment of Glabellar Lines
Mark Rubin, MD; Jeffrey Dover, MD, FRCPC; Corey Maas, MD; and Mark Nestor, MD, PhD
Aesthetic Surgery Journal
By Corey S. Maas MD™
October 23, 2011
Recent Posts
Daxxify — Better Than Botox?
November 29, 2022
The Top Plastic Surgery Trends of 2022
May 26, 2022
Body Contouring: CoolSculpting vs. VelaShape
March 29, 2021
Can Platelet Rich Plasma Restore Lost Hair?
February 20, 2020
Schedule Consultation
Maas Clinic Patient Portal
Use myTouchMD to access important documents and information regarding your visits.
